Zenas biopharma, inc. investor news: if you have suffered losses in zenas biopharma, inc. (nasdaq: zbio), you are encouraged to contact the rosen law firm about your rights

New york, april 10, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of zenas biopharma, inc. (nasdaq: zbio) resulting from allegations that zenas biopharma may have issued materially misleading business information to the investing public. so what: if you purchased zenas biopharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
EA Ratings Summary
EA Quant Ranking